Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2026 08:51 ET | Source: Kartoon Studios

Kartoon Studios Provides Business Update

CEO AND CFO PROVIDE GROUNDBREAKING AI ANIMATED EARNINGS UPDATE IN INTERVIEW WITH A.A. MILNE’S WINNIE THE POOH, AND TENTPOLE CHARACTERS OVERALL REVENUE INCREASED YEAR-OVER-YEAR 21% IN 2025 TO $39.4...
March 31, 2026 08:30 ET | Source: Nuwellis, Inc.

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

MINNEAPOLIS, March 31, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces...
March 31, 2026 08:00 ET | Source: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies

MONTREAL and CHARLOTTE, N.C., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and...
March 31, 2026 07:30 ET | Source: BrightSpring Health Services, Inc.

BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita

LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and...
March 31, 2026 07:00 ET | Source: Chuck E. Cheese

CHUCK E. CHEESE INTRODUCES SENSORY SENSITIVE BIRTHDAYS THIS WORLD AUTISM MONTH

Irving, Texas, March 31, 2026 (GLOBE NEWSWIRE) -- Chuck E. Cheese, the Birthday Capital of the Universe®, is kicking off World Autism Month with the launch of new Sensory Sensitive Birthdays on...
March 31, 2026 03:01 ET | Source: ALK Abello

EURneffy 1 mg approved across the EU as the first and only needle-free adrenaline treatment for young children (≥15 kg) at risk of anaphylaxis

Today, ALK announced that children aged 4 and older living with severe allergies across the EU can now access the first and only needle-free adrenaline treatment for anaphylaxis, after the European...
March 31, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Rezurock is now approved in the EU for adults and children aged 12 years and older with chronic GVHD, providing a new...
March 30, 2026 21:41 ET | Source: Pelvic Floor Strong

Pelvic Floor Strong Exercise Claims Evaluated (2026) Therapeutic Ways to Strengthen Pelvic Floor Muscles for Women

Pelvic Floor Strong exercise claims, Layer Syndrome framework, and Alex Miller's three-step pelvic floor method for women over 40 outlined.
March 30, 2026 18:41 ET | Source: MemoryON

MemoryON Claims Evaluated: Hidden Details Emerge About Memory On Brain Support Supplementation for Memory Loss

2026 report covers MemoryON ingredient dosages, Bacopa and Phosphatidylserine research context, St. John's Wort safety, and pricing details.
March 30, 2026 16:01 ET | Source: Praxis Precision Medicines, Inc.

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

FDA assigned PDUFA target action date of September 27, 2026 BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous...